Laboratory News and Research

RSS

Researchers validate effectiveness of genome sequencing process for hereditary genetic diseases

A research team led by Dr. Nada Jabado at the MUHC Research Institute and Dr. Jacek Majewski at McGill University has proven for the first time that it is possible to identify any genetic disease in record time thanks to a powerful and reliable exome sequencing method. The exome, a small part of the genome ((less than) 2%), is of crucial interest with regard to research on genetic diseases as it accounts for 85% of mutations.

10 Jun 2010

MicroConstants adds second Waters Xevo TQ MS system

MicroConstants, Inc., a bioanalytical and pharmacokinetic-specialty Contract Research Organization (CRO) in San Diego, California, announces the continued expansion of its bioanalytical capacity through the addition of a second Waters Xevo TQ MS system. The CRO has also appointed a new East Coast business development manager to actively pursue new business opportunities in that region.

10 Jun 2010

LAB Research completes development of novel drug investigation model

LAB Research Inc., a Canadian-based global non-clinical contract research organization, today announced that it has recently completed development of a novel drug investigation model focused on biodistribution and pharmacokinetic of biologics.

10 Jun 2010

Clarient becomes preferred genetic testing lab for Generation Health

Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced a new contractual agreement with Generation Health, Inc. (GH). This agreement makes Clarient a preferred genetic testing lab for GH, thereby ensuring reimbursement of diagnostic tests done for GH's nationwide network of payor clients and expanding Clarient's potential market. GH is a genetic benefit management company partially-owned by CVS Caremark, the nation's largest pharmacy healthcare provider.

10 Jun 2010

Investigative Workshop aims to discuss current achievements, challenges in modeling solid tumors

With high human mortality associated with cancerous tumors, there is a worldwide need for a better understanding of why a tumor starts to grow and what makes it continue to grow. Mathematical modeling can provide some of the answers.

10 Jun 2010

New study finds propofol poses low risk for children undergoing research-driven imaging studies

A new study finds that propofol, a well-known anesthesia medication, has a low occurrence of adverse events for children undergoing research-driven imaging studies. The study, led by a pediatric anesthesiologist now at Children's National Medical Center, showed a low incidence of adverse events and no long term complications when propofol was used to sedate children for imaging studies that require them to be still for long periods of time.

10 Jun 2010

Study suggests potential of ARC man-made compound in combination with Abbott's ABT-737 for cancer

Adding a second agent may make a new, experimental anti-cancer drug effective against a wide range of cancers, researchers at the University of Illinois at Chicago College of Medicine have found.

10 Jun 2010

ICON launches ICOLabs Medical Review Application

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the launch of the ICOLabs Medical Review Application an innovative web based laboratory application that enables more efficient use of medical monitoring time.

10 Jun 2010

Voices Against Brain Cancer's fifth annual gala to fight brain cancer

Voices Against Brain Cancer's fifth annual gala, Sounding Off For A Cure, to fight brain cancer. Proceeds from the event will benefit innovative brain cancer research programs at, Columbia, Cornell, Duke, Harvard, Memorial Sloan-Kettering, University of Michigan, University of Pittsburg and Brookhaven National Laboratory.

10 Jun 2010

DermaGenoma releases CelluliteDX Genetic Test for women

As summer swimsuit season heats up, women around the world will inspect their looks in the mirror. A majority of them will see cellulite - at some point - but a new genetic test may be able to help them avoid cellulite before anyone notices.

10 Jun 2010

Researchers develop new tool for removing blood clots in brain

When someone suffers a stroke, time is critical--more than a million brain cells die each minute, starved of nourishment due to critical damage in a cerebral blood vessel.

10 Jun 2010

CoLucid's lasmiditan NAAMA effective in treatment of acute migraine attacks

CoLucid Pharmaceuticals, Inc.,, an innovative biotechnology company focusing on therapies for central nervous system disorders, today announced that its investigational first-in-class Neurally Acting Anti-Migraine Agent (NAAMA), lasmiditan (also known as COL-144), a selective 5-HT1F receptor agonist, was effective when given orally to treat acute migraine attacks, as documented in a Phase IIb study.

10 Jun 2010

Dartmouth-Hitchcock Medical Center to implement BioImagene's digital pathology solutions

BioImagene, the leading provider of innovative digital pathology solutions, today announced that they have signed an agreement to equip Dartmouth-Hitchcock Medical Center (DHMC) with their complete suite of digital pathology solutions. DHMC will use iScan Coreo Au™ slide scanner and Virtuoso™ digital pathology application software to streamline laboratory workflow and enhance the Pathology Department's educational and residency programs.

10 Jun 2010

Drinking coffee may help prevent diabetes, report scientists

Scientists are reporting new evidence that drinking coffee may help prevent diabetes and that caffeine may be the ingredient largely responsible for this effect. Their findings, among the first animal studies to demonstrate this apparent link, appear in ACS' bi-weekly Journal of Agricultural and Food Chemistry.

10 Jun 2010

Abnormalities in the process of blood clot formation contribute to pathogenesis of AD: Research

New research suggests that abnormalities in the process of blood clot formation may contribute to the pathogenesis of Alzheimer's disease. The study, published by Cell Press in the June 10 issue of the journal Neuron, advances our understanding of the link between vascular pathology and AD and proposes a new therapeutic strategy aimed at slowing cognitive decline.

10 Jun 2010

Union Hospital joins Indiana Network for Patient Care

The Indiana Network for Patient Care (INPC) is expanding to serve patients in Terre Haute and Clinton, Indiana. Union Hospital joins 60 hospitals serving more than 6 million patients throughout the state in a network that allows physicians to securely access necessary information to make decisions critical to patient care.

9 Jun 2010

Hooper Holmes launches iParamed Expedite for insurance applications

Hooper Holmes today introduced iParamed Expedite, a new service that cuts costs and improves accuracy for insurance applications. It is six to seven days faster than current approaches and has been designed to quickly and accurately qualify applicants for life, long-term care, health and Medicare Supplement insurance policies.

9 Jun 2010

QuantRx Biomedical completes clinical testing of Q-Reader thyroid testing system

QuantRx Biomedical Corporation, a broad-based diagnostic company focused on the development and commercialization of innovative diagnostic products, today announced that it has completed clinical testing of the Q-Reader thyroid testing system.

9 Jun 2010

New AAN guideline provides step-by-step process for determining brain death in adults

In an effort to create a uniform and accurate method for determining brain death, the American Academy of Neurology has issued an updated guideline that provides doctors with a step-by-step process for determining brain death in adults. The guideline is published in the June 8, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.

9 Jun 2010

Purdue University researchers develop potential new tool for medical diagnostics, testing food

Researchers at Purdue University have developed a potential new tool for medical diagnostics, testing food and water for contamination, and crime-scene forensics.

9 Jun 2010

Laboratory News and Research

Researchers validate effectiveness of genome sequencing process for hereditary genetic diseases

MicroConstants adds second Waters Xevo TQ MS system

LAB Research completes development of novel drug investigation model

Clarient becomes preferred genetic testing lab for Generation Health

Investigative Workshop aims to discuss current achievements, challenges in modeling solid tumors

New study finds propofol poses low risk for children undergoing research-driven imaging studies

Study suggests potential of ARC man-made compound in combination with Abbott's ABT-737 for cancer

ICON launches ICOLabs Medical Review Application

Voices Against Brain Cancer's fifth annual gala to fight brain cancer

DermaGenoma releases CelluliteDX Genetic Test for women

Researchers develop new tool for removing blood clots in brain

CoLucid's lasmiditan NAAMA effective in treatment of acute migraine attacks

Dartmouth-Hitchcock Medical Center to implement BioImagene's digital pathology solutions

Drinking coffee may help prevent diabetes, report scientists

Abnormalities in the process of blood clot formation contribute to pathogenesis of AD: Research

Union Hospital joins Indiana Network for Patient Care

Hooper Holmes launches iParamed Expedite for insurance applications

QuantRx Biomedical completes clinical testing of Q-Reader thyroid testing system

New AAN guideline provides step-by-step process for determining brain death in adults

Purdue University researchers develop potential new tool for medical diagnostics, testing food

Viva Saliva Book: The ultimate guide to saliva Book preview Download eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo